Advanced Search


Study ID Status Title Patient Level Data
113722 Completed A single-dose, open, randomized, crossover investigation of age, gender, food-effect and proton-pump interaction on the pharmacokinetics of GSK1325756 in healthy adult subjects and a single-dose, double blind, parallel-group, placebo- controlled investigation of the pharmacokinetics of GSK1325756 Study Listed on
113734 Completed A Prospective, Randomized, Multicenter, Open-Label Study to Compare the Efficacy and Safety of Simplifying from a Regimen of Atazanavir (ATV) + Ritonavir (RTV) + Tenofovir/Emtricitabine to ATV + Abacavir/Lamivudine Without RTV in Virologically Suppressed, HIV-1 Infected, HLA-B*5701 Negative Subjects
113746 Completed A double blind, randomized, placebo controlled, cross-over study to Examine the pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in nicotine abstained otherwise healthy smokers Study Listed on
113747 Completed A 24-week, Phase IIB, Randomized, Controlled, Parallel group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects with Anemia Associated with Chronic Kidney Diseases who are not on Dialysis.
113748 Completed A randomized, placebo-controlled, double-masked, parallel group study to evaluate the safety, tolerability, and pharmacokinetic profile of repeat doses of pazopanib eye drops in healthy adult subjects
113750 Active, not recruiting GSK1550188 A 52 week study of belimumab versus placebo in the treatment of subjects with systemic lupus erythematosus (SLE) located in Northeast Asia
113758 Relinquished A randomized, open-label, Phase II, 2-arm multi-center trial comparing maintenance therapy with pazopanib or pemetrexed in non-progressing subjects with metastatic stage IVA and IVB non-squamous Non-small Cell Lung Cancer (NSCLC) after induction therapy with carboplatin + pemetrexed or cisplatin + pemetrexed
113761 Completed TZV Epidemiology Program of HSR and Rechallenge HSR: HIV Insight
113762 Completed TZV Epidemiology Program of HSR and Rechallenge HSR: CHORUS
113765 Relinquished A Multicenter, Randomized, Double-Blind and Open-label Phase III Study To Compare The Efficacy And Safety Of Eltrombopag With Placebo In Chinese Chronic ITP Patients
113771 Relinquished A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin and the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on the Repeat Dose Pharmacokinetics of GSK2118436, and the Repeat Dose Pharmacokinetics of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113773 Relinquished A Two-Part Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects with V600 BRAF Mutation-Positive Tumors: An Open-label, Dose-escalating Safety Lead-in Study Followed by a Single-sequence, Placebo-controlled, Single-blind Study
113776 Completed A Phase 1 dose escalation study to investigate the pharmacokinetics, pharmacodynamics, safety, and tolerability of single intravenous doses of GSK2315698A in healthy volunteers
113779 Completed A study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of administering multiple oral doses of GSK1292263 alone and with atorvastatin
113782 Completed A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease Study Listed on
113783 Completed A Fixed-Dose Study of Lamotrigine versus Placebo in the Long Term Prevention of Relapse and/or Recurrence of a Manic, Hypomanic, Mixed or Depressive Episode in Adult Subjects with Bipolar I Disorder
113789 Completed A Randomized, Placebo-Controlled, Double-Blind, Four-way Crossover Study to Assess the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, with Moxifloxacin as a Positive Control in Healthy Volunteers Study Listed on
113794 Terminated A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects with Advanced Solid Tumors.
113797 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and effectiveness of AVODART® administered in Korean androgenetic alopecia patients according to the prescribing information
113806 Relinquished An open-label, single-arm, Phase I/II study of lapatinib in combination with weekly paclitaxel as first-line chemotherapy for ErbB2-overexpressing Metastatic Breast Cancer patients
113807 Relinquished Phase IIIb immunogenicity, safety and reactogenicity study of GSK Biologicals’ meningococcal vaccine [GSK 134612] when given as one dose to healthy subjects aged 56 years or older Study Listed on
113808 Completed Efficacy, immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Liquid Human Rotavirus (HRV) Vaccine (444563), in healthy infants Study Listed on
113809 Completed Immunological non-inferiority between two process-manufactured influenza vaccines in adults aged 18 to 60 years Study Listed on
113810 Terminated Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 9 years Study Listed on
113813 Completed The prevalence of sleep disturbance in patients with parkinson's disease in Korea



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.